Additionally, Harvey and colleagues demonstrated that sCAR-fusion proteins retargeted to urokinase-type plasminogen activator receptor (uPAR) and EGFR, improved the transduction of a number of carcinoma cell lines [271]. This evidence concerns the gene EGFR and carcinoma.